Cargando…

Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)

The novel adipokine chemerin has been related to insulin-resistant states such as obesity and non alcoholic fatty liver disease (NAFLD). However, its association with insulin resistance and beta cell function remains controversial. The main objective was to examine whether serum chemerin levels asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatziagelaki, Erifili, Herder, Christian, Tsiavou, Anastasia, Teichert, Tom, Chounta, Athina, Nowotny, Peter, Pacini, Giovanni, Dimitriadis, George, Roden, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416815/ https://www.ncbi.nlm.nih.gov/pubmed/25933030 http://dx.doi.org/10.1371/journal.pone.0124935

Ejemplares similares

Predictors of Impaired Glucose Regulation in Patients with Non-Alcoholic Fatty Liver Disease
por: Hatziagelaki, Erifili, et al.
Publicado: (2012)

Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus
por: Zhang, Zhengjun, et al.
Publicado: (2018)

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
por: Tsoporis, James N., et al.
Publicado: (2020)

Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos(®) on parasympathetic tone and hepatic energy metabolism
por: Gancheva, Sofiya, et al.
Publicado: (2017)

Effects of olanzapine on cytokine profile and brain-derived neurotrophic factor in drug-naive subjects with first-episode psychosis
por: Hatziagelaki, Erifili, et al.
Publicado: (2019)

Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans
por: Wagner, Robert, et al.
Publicado: (2014)

Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion
por: Dimitriadis, Georgios K., et al.
Publicado: (2018)

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
por: Pafili, Kalliopi, et al.
Publicado: (2020)

Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans
por: Apostolopoulou, Maria, et al.
Publicado: (2020)

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009)

Lipid-Induced Insulin Resistance Is Not Mediated by Impaired Transcapillary Transport of Insulin and Glucose in Humans
por: Szendroedi, Julia, et al.
Publicado: (2012)

Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
por: Levin, Lena-Maria, et al.
Publicado: (2019)

Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer
por: Eichelmann, Fabian, et al.
Publicado: (2019)

Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
por: Theoharides, Theoharis C., et al.
Publicado: (2015)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease
por: Lambadiari, Vaia, et al.
Publicado: (2014)

Serum and adipose tissue chemerin is differentially related to insulin sensitivity
por: Karczewska-Kupczewska, Monika, et al.
Publicado: (2020)

Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma
por: Haberl, Elisabeth M., et al.
Publicado: (2020)

Chemerin and Cancer
por: Treeck, Oliver, et al.
Publicado: (2019)

Evaluation of Quality of Life and Emotional Disturbances in Patients with Diabetic Retinopathy
por: Saitakis, George, et al.
Publicado: (2023)

Insulin resistance and its correlation with chemerin and visfatin in Saudi patients with hyperthyroidism
por: Al Doghaither, Huda A., et al.
Publicado: (2019)

Prenatal and Childhood Growth, Chemerin Concentrations, and Metabolic Health in Adult Life
por: Eriksson, Johan G., et al.
Publicado: (2016)

Analysis of serum chemerin concentrations in psoriatic patients in relation to metabolic abnormalities
por: Chyl-Surdacka, Katarzyna M., et al.
Publicado: (2019)

Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
por: Szpakowicz, Anna, et al.
Publicado: (2021)

Diet, life-style and cardiovascular morbidity in the rural, free living population of Elafonisos island
por: Kapelios, Chris J., et al.
Publicado: (2017)

Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E
por: Carstensen-Kirberg, Maren, et al.
Publicado: (2019)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Mechanisms Underlying the Onset of Oral Lipid–Induced Skeletal Muscle Insulin Resistance in Humans
por: Nowotny, Bettina, et al.
Publicado: (2013)

Chemerin Signaling in Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
por: Gaggini, Melania, et al.
Publicado: (2013)

Regulatory effect of chemerin and therapeutic efficacy of chemerin-9 in pancreatogenic diabetes mellitus
por: Tu, Jianfeng, et al.
Publicado: (2020)

Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis
por: Al Delbany, Diana, et al.
Publicado: (2021)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes
por: Kapitza, Christoph, et al.
Publicado: (2020)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Carneros, David, et al.
Publicado: (2020)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkce5lsnjidu6cg6sumujm88jq